Antibody response to influenza vaccination in the elderly: a quantitative review.

[1]  N. Cox,et al.  Prevention and Control of Influenza: recommendations of the Advisory Committee on Immunization Practices (ACIP). , 2006, MMWR. Recommendations and reports : Morbidity and mortality weekly report. Recommendations and reports.

[2]  Cecile Viboud,et al.  Impact of influenza vaccination on seasonal mortality in the US elderly population. , 2005, Archives of internal medicine.

[3]  Yoshio Hirota,et al.  Immune response to influenza vaccine in healthy adults and the elderly: association with nutritional status. , 2005, Vaccine.

[4]  G. Glenn,et al.  Improved immune responses to influenza vaccination in the elderly using an immunostimulant patch. , 2005, Vaccine.

[5]  F. Newman,et al.  Serum antibody responses after intradermal vaccination against influenza. , 2004, The New England journal of medicine.

[6]  B. Ruf,et al.  Open, Randomized Study to Compare the Immunogenicity and Reactogenicity of an Influenza Split Vaccine with an MF59-Adjuvanted Subunit Vaccine and a Virosome-Based Subunit Vaccine in Elderly , 2004, Infection.

[7]  I. Kang,et al.  Age-Associated Change in the Frequency of Memory CD4+ T Cells Impairs Long Term CD4+ T Cell Responses to Influenza Vaccine1 , 2004, The Journal of Immunology.

[8]  Jennifer A. Roberts,et al.  A cohort study of the effectiveness of influenza vaccine in older people, performed using the United Kingdom general practice research database. , 2004, The Journal of infectious diseases.

[9]  Yuping Deng,et al.  Age-Related Impaired Type 1 T Cell Responses to Influenza: Reduced Activation Ex Vivo, Decreased Expansion in CTL Culture In Vitro, and Blunted Response to Influenza Vaccination In Vivo in the Elderly1 , 2004, The Journal of Immunology.

[10]  J. Myśliwska,et al.  Immune Response to Influenza Vaccination in an Elderly Population , 2003, Journal of Clinical Immunology.

[11]  P. Szabo,et al.  The Effect of Age on the B-Cell Repertoire , 2000, Journal of Clinical Immunology.

[12]  M. Muszkat,et al.  Response to influenza vaccination in community and in nursing home residing elderly: relation to clinical factors , 2003, Experimental Gerontology.

[13]  L. Biasio,et al.  Comparison of the reactogenicity and immunogenicity of a split and a subunit-adjuvanted influenza vaccine in elderly subjects. , 2003, Vaccine.

[14]  M. Muszkat,et al.  Local and systemic immune response in nursing-home elderly following intranasal or intramuscular immunization with inactivated influenza vaccine. , 2003, Vaccine.

[15]  Keiji Fukuda,et al.  Mortality associated with influenza and respiratory syncytial virus in the United States. , 2003, JAMA.

[16]  Walther Parson,et al.  Lack of Antibody Production Following Immunization in Old Age: Association with CD8+CD28− T Cell Clonal Expansions and an Imbalance in the Production of Th1 and Th2 Cytokines1 , 2002, The Journal of Immunology.

[17]  G. Jonson,et al.  The humoral response to live and inactivated influenza vaccines administered alone and in combination to young adults and elderly. , 2002, Journal of clinical virology : the official publication of the Pan American Society for Clinical Virology.

[18]  Trang Vu,et al.  A meta-analysis of effectiveness of influenza vaccine in persons aged 65 years and over living in the community. , 2002, Vaccine.

[19]  E. Gardner,et al.  Role of humoral and cell-mediated immunity in protection from influenza disease after immunization of healthy elderly , 2002, Experimental Gerontology.

[20]  W. O'Fallon,et al.  Value of Immunological Markers in Predicting Responsiveness to Influenza Vaccination in Elderly Individuals , 2001, Journal of Virology.

[21]  E. Gardner,et al.  Characterization of antibody responses to annual influenza vaccination over four years in a healthy elderly population. , 2001, Vaccine.

[22]  A. Floreani,et al.  Comparison of three different influenza vaccines in institutionalised elderly. , 2001, Vaccine.

[23]  F. Pregliasco,et al.  Immunogenicity and safety of three commercial influenza vaccines in institutionalized elderly , 2001, Aging.

[24]  E. Gardner,et al.  Immune response to influenza vaccine in healthy elderly: lack of association with plasma β-carotene, retinol, α-tocopherol, or zinc , 2000, Mechanisms of Ageing and Development.

[25]  B. Lina,et al.  A TritonX-100-split virion influenza vaccine is safe and fulfills the committee for proprietary medicinal products (CPMP) recommendations for the European Community for Immunogenicity, in Children, Adults and the Elderly. , 2000, Biologicals : journal of the International Association of Biological Standardization.

[26]  R. Holman,et al.  Decreased antibody response among nursing home residents who received recalled influenza vaccine and results of revaccination, 1996-97. , 2000, Vaccine.

[27]  E. Gardner,et al.  Immune response to influenza vaccine in healthy elderly: lack of association with plasma beta-carotene, retinol, alpha-tocopherol, or zinc. , 2000, Mechanisms of ageing and development.

[28]  M. Faccini,et al.  Safety and immunogenicity of MF59-adjuvanted influenza vaccine in the elderly. , 1999, Vaccine.

[29]  P. Gross,et al.  Immune response to influenza vaccination in a large healthy elderly population. , 1999, Vaccine.

[30]  A. Podda,et al.  Safety and immunogenicity of an inactivated subunit influenza virus vaccine combined with MF59 adjuvant emulsion in elderly subjects, immunized for three consecutive influenza seasons. , 1999, Vaccine.

[31]  I. Donatelli,et al.  Antibody Response to 1995–1996 Influenza Vaccine in Institutionalized and Non-Institutionalized Elderly Women , 1998, Gerontology.

[32]  G. Ligthart,et al.  Altered antibody response to influenza H1N1 vaccine in healthy elderly people as determined by HI, ELISA, and neutralization assay , 1998, Journal of medical virology.

[33]  B. Grubeck‐Loebenstein,et al.  Primary and secondary alterations of immune reactivity in the elderly: impact of dietary factors and disease , 1997, Immunological reviews.

[34]  S. le Cessie,et al.  Annually repeated influenza vaccination improves humoral responses to several influenza virus strains in healthy elderly. , 1997, Vaccine.

[35]  P. Gross,et al.  Time to earliest peak serum antibody response to influenza vaccine in the elderly , 1997, Clinical and diagnostic laboratory immunology.

[36]  V. Prikazsky,et al.  Immunogenicity of an inactivated split influenza vaccine in institutionalized elderly patients. , 1996, Gerontology.

[37]  P. Gross,et al.  Time to peak serum antibody response to influenza vaccine , 1995, Clinical and diagnostic laboratory immunology.

[38]  G. Dinant,et al.  The Efficacy of Influenza Vaccination in Elderly Individuals: A Randomized Double-blind Placebo-Controlled Trial , 1994 .

[39]  P. Gross,et al.  Vaccine immune response and side effects with the use of acetaminophen with influenza vaccine , 1994, Clinical and diagnostic laboratory immunology.

[40]  L. Pickard,et al.  Immunogenicity and adverse reactions of influenza vaccination in elderly patients given acetaminophen or placebo. , 1993, Clinical and Diagnostic Virology.

[41]  A. Grosche,et al.  Comparison of humoral immune responses to trivalent influenza split vaccine in young, middle-aged and elderly people. , 1993, Vaccine.

[42]  R. Belshe,et al.  Effect of age on cytotoxic T lymphocyte memory as well as serum and local antibody responses elicited by inactivated influenza virus vaccine. , 1993, The Journal of infectious diseases.

[43]  W. Beyer,et al.  Antibody response after influenza immunization with various vaccine doses: a double-blind, placebo-controlled, multi-centre, dose-response study in elderly nursing-home residents and young volunteers. , 1993, Vaccine.

[44]  B. L. Beattie,et al.  Antibody response to whole-virus and split-virus influenza vaccines in successful ageing. , 1993, Vaccine.

[45]  A. Iorio,et al.  Immunogenicity of trivalent subunit and split influenza vaccines (1989-90 winter season) in volunteers of different groups of age. , 1991, Vaccine.

[46]  W. Beyer,et al.  Antibody induction by influenza vaccines in the elderly: a review of the literature. , 1989, Vaccine.

[47]  R. Douglas,et al.  Relation of chronic disease and immune response to influenza vaccine in the elderly. , 1989, Vaccine.

[48]  R. Douglas,et al.  Immunization of elderly people with two doses of influenza vaccine , 1987, Journal of clinical microbiology.

[49]  H. Müller-Hermelink,et al.  Admission criteria for immunogerontological studies in man: The senieur protocol , 1984, Mechanisms of Ageing and Development.

[50]  C W Potter,et al.  Determinants of immunity to influenza infection in man. , 1979, British medical bulletin.

[51]  M. Thibon,et al.  Antibody response to anti-A/New Jersey/76 vaccines. , 1977, Developments in biological standardization.

[52]  A. S. Beare,et al.  The role of serum haemagglutination-inhibiting antibody in protection against challenge infection with influenza A2 and B viruses , 1972, Epidemiology and Infection.

[53]  Mclean Iw,et al.  Influenza Immunization: A New Vaccine , 1969 .

[54]  I. McLean,et al.  Influenza immunization. A new vaccine. , 1969, JAMA.